Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis

European Journal of Human Genetics

Volumn 18, Issue 2, 2010, Pages 186-193

  Douma, Kirsten F L ^a   Aaronson, Neil K ^a   Vasen, Hans F A ^b,c   Verhoef, Senno ^a   Gundy, Chad M ^a   Bleiker, Eveline M A ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b Foundation for the Detection of Hereditary Tumours   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Children; Familial adenomatous polyposis; Genetic screening; Preimplantation genetic diagnosis; Prenatal diagnosis; Reproductive decision making

Indexed keywords

ADENOMATOUS POLYP; ADULT; ARTICLE; ATTITUDE TO ABORTION; DECISION MAKING; FAMILY PLANNING; FEMALE; GENETIC RISK; GENETIC SCREENING; HUMAN; MALE; PARENTAL ATTITUDE; PERSONAL EXPERIENCE; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

ADENOMATOUS POLYPOSIS COLI; ADULT; ATTITUDE TO HEALTH; CHILD; CROSS-SECTIONAL STUDIES; DECISION MAKING; DEMOGRAPHY; DNA; EDUCATIONAL STATUS; FAMILY; FAMILY CHARACTERISTICS; FEMALE; GENETIC TESTING; HUMANS; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; PARENTS; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRES;

EID: 74449093000     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.151     Document Type: Article

References (26)

1. Lynch HT, de la Chapelle A: Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-932.
2. Vasen HF, Moeslein G, Alonso A et al: Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57: 704-713.
3. Ao A, Wells D, Handyside AH, Winston RM, Delhanty JD: Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli. J Assist Reprod Genet 1998; 15: 140-144.
4. Dalton A, Shannon NL, Johnson M, Cook J: Prenatal diagnosis to exclude FAP in a high risk pregnancy. Prenat Diagn 1998; 18: 756.
5. Moutou C, Gardes N, Nicod JC, Viville S: Strategies and outcomes of PGD of familial adenomatous polyposis. Mol Hum Reprod 2007; 13: 95-101.
6. Wagner TM, Ahner R: Prenatal testing for late-onset diseases such as mutations in the breast cancer gene 1 (BRCA1). Just a choice or a step in the wrong direction? Hum Reprod 1998; 13: 1125-1126.
7. Offit K, Kohut K, Clagett B et al: Cancer genetic testing and assisted reproduction. J Clin Oncol 2006; 24: 4775-4782.
8. Lavery SA, Aurell R, Turner C et al: Preimplantation genetic diagnosis: patients' experiences and attitudes. Hum Reprod 2002; 17: 2464-2467.
9. Kastrinos F, Stoffel EM, Balmana J, Syngal S: Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am J Gastroenterol 2007; 102: 1284-1290.
10. Whitelaw S, Northover JM, Hodgson SV: Attitudes to predictive DNA testing in familial adenomatous polyposis. J Med Genet 1996; 33: 540-543.
11. Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Niermeijer MF: Attitudes towards termination of pregnancy in subjects who underwent presympto-matic testing for the BRCA1/BRCA2 gene mutation in the Netherlands. J Med Genet 2000; 37: 883-884.
12. Bleiker EMA, Menko FH, Kluijt I et al: Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling. Hered Cancer Clin Pract 2007; 5: 59-66.
13. Aaronson NK, Muller M, Cohen PD et al: Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055-1068.
14. Lerman C, Daly M, Masny A, Balshem A: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994; 12: 843-850. (Pubitemid 24110927)
15. Watson M, Duvivier V, Wade Walsh M et al: Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998; 35: 731-738.
16. Horowitz MJ: Stress response syndromes and their treatment; in Goldberger L, Breznitz S (eds): Handbook of Stress. Theoretical and Clinical Aspects. London: Collier Macmillan Publishers, 1982, pp 711-732.
17. Lerman C, Seay J, Balshem A, Audrain J: Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995; 57: 385-392.
18. Menon U, Harper J, Sharma A et al: Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod 2007; 22: 1573-1577.
19. Quinn G, Vadaparampil S, Wilson C et al: Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertil Steril 2009; 91: 2361-2368.
20. Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K: Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet 2006; 70: 374-381.
21. Staton AD, Kurian AW, Cobb K, Mills MA, Ford JM: Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Fam Cancer 2008; 7: 179-186.
22. Tibben A, Frets PG, van de Kamp JJ et al: Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet 1993; 48: 10-16.
23. Adam S, Wiggins S, Whyte P et al: Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment. J Med Genet 1993; 30: 549-556.
24. Preimplantation genetic diagnosis-for or against humanity? Lancet 2004; 364: 1729-1730.
25. Peshkin BN, Nusbaum RH, DeMarco TA: Genetic counseling about reproductive options for hereditary cancer: what is the standard of care? J Clin Oncol 2007; 25: 911-912.
26. Twisk JWR: Applied Multilevel Analysis: A Practical Guide for Medical Researchers. Cambridge University Press: Cambridge, 2006.